A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body

Clinical trial NCT07525960 · RECRUITING

Trial details

NCT number: NCT07525960
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Insipidus

Start date: 2026-07-07
Primary completion: 2027-08-25
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.